Cargando…

Monte Carlo simulation of physical dose enhancement in core-shell magnetic gold nanoparticles with TOPAS

The application of metal nanoparticles (MNPs) as sensitization materials is a common strategy that is used to study dose enhancement in radiotherapy. Recent in vitro tests have revealed that magnetic gold nanoparticles (NPs) can be used in cancer therapy under a magnetic field to enhance the synergi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaohan, Wu, Jianan, Dai, Zhitao, Hu, Rui, Xie, Yaoqin, Wang, Luhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516316/
https://www.ncbi.nlm.nih.gov/pubmed/36185221
http://dx.doi.org/10.3389/fonc.2022.992358
_version_ 1784798681881378816
author Xu, Xiaohan
Wu, Jianan
Dai, Zhitao
Hu, Rui
Xie, Yaoqin
Wang, Luhua
author_facet Xu, Xiaohan
Wu, Jianan
Dai, Zhitao
Hu, Rui
Xie, Yaoqin
Wang, Luhua
author_sort Xu, Xiaohan
collection PubMed
description The application of metal nanoparticles (MNPs) as sensitization materials is a common strategy that is used to study dose enhancement in radiotherapy. Recent in vitro tests have revealed that magnetic gold nanoparticles (NPs) can be used in cancer therapy under a magnetic field to enhance the synergistic efficiency in radiotherapy and photothermal therapy. However, magnetic gold NPs have rarely been studied as sensitization materials. In this study, we obtained further results of the sensitization properties of the magnetic gold NPs (Fe(3)O(4)@AuNPs) with or without magnetic field using the TOPAS-nBio Monte Carlo (MC) toolkit. We analyzed the properties of Fe(3)O(4)@AuNP in a single NP model and in a cell model under monoenergetic photons and brachytherapy, and we investigated whether the magnetic field contributes to the physical sensitization process. Our results revealed that the dose enhancement factor (DEF) of Fe(3)O(4)@AuNPs was lower than that of gold nanoparticles (AuNPs) in a single NP and in a cell irradiated by monoenergetic photons. But it’s worth mentioning that under a magnetic field, the DEF of targeted Fe(3)O(4)@AuNPs in a cell model with a clinical brachytherapy source was 22.17% (cytoplasm) and 6.89% (nucleus) higher than those of AuNPs (50 mg/mL). The Fe(3)O(4)@AuNPs were proved as an effective sensitization materials when combined with the magnetic field in MC simulation for the first time, which contributes to the research on in vitro tests on radiosensitization as well as clinical research in future.
format Online
Article
Text
id pubmed-9516316
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95163162022-09-29 Monte Carlo simulation of physical dose enhancement in core-shell magnetic gold nanoparticles with TOPAS Xu, Xiaohan Wu, Jianan Dai, Zhitao Hu, Rui Xie, Yaoqin Wang, Luhua Front Oncol Oncology The application of metal nanoparticles (MNPs) as sensitization materials is a common strategy that is used to study dose enhancement in radiotherapy. Recent in vitro tests have revealed that magnetic gold nanoparticles (NPs) can be used in cancer therapy under a magnetic field to enhance the synergistic efficiency in radiotherapy and photothermal therapy. However, magnetic gold NPs have rarely been studied as sensitization materials. In this study, we obtained further results of the sensitization properties of the magnetic gold NPs (Fe(3)O(4)@AuNPs) with or without magnetic field using the TOPAS-nBio Monte Carlo (MC) toolkit. We analyzed the properties of Fe(3)O(4)@AuNP in a single NP model and in a cell model under monoenergetic photons and brachytherapy, and we investigated whether the magnetic field contributes to the physical sensitization process. Our results revealed that the dose enhancement factor (DEF) of Fe(3)O(4)@AuNPs was lower than that of gold nanoparticles (AuNPs) in a single NP and in a cell irradiated by monoenergetic photons. But it’s worth mentioning that under a magnetic field, the DEF of targeted Fe(3)O(4)@AuNPs in a cell model with a clinical brachytherapy source was 22.17% (cytoplasm) and 6.89% (nucleus) higher than those of AuNPs (50 mg/mL). The Fe(3)O(4)@AuNPs were proved as an effective sensitization materials when combined with the magnetic field in MC simulation for the first time, which contributes to the research on in vitro tests on radiosensitization as well as clinical research in future. Frontiers Media S.A. 2022-09-14 /pmc/articles/PMC9516316/ /pubmed/36185221 http://dx.doi.org/10.3389/fonc.2022.992358 Text en Copyright © 2022 Xu, Wu, Dai, Hu, Xie and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Xu, Xiaohan
Wu, Jianan
Dai, Zhitao
Hu, Rui
Xie, Yaoqin
Wang, Luhua
Monte Carlo simulation of physical dose enhancement in core-shell magnetic gold nanoparticles with TOPAS
title Monte Carlo simulation of physical dose enhancement in core-shell magnetic gold nanoparticles with TOPAS
title_full Monte Carlo simulation of physical dose enhancement in core-shell magnetic gold nanoparticles with TOPAS
title_fullStr Monte Carlo simulation of physical dose enhancement in core-shell magnetic gold nanoparticles with TOPAS
title_full_unstemmed Monte Carlo simulation of physical dose enhancement in core-shell magnetic gold nanoparticles with TOPAS
title_short Monte Carlo simulation of physical dose enhancement in core-shell magnetic gold nanoparticles with TOPAS
title_sort monte carlo simulation of physical dose enhancement in core-shell magnetic gold nanoparticles with topas
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516316/
https://www.ncbi.nlm.nih.gov/pubmed/36185221
http://dx.doi.org/10.3389/fonc.2022.992358
work_keys_str_mv AT xuxiaohan montecarlosimulationofphysicaldoseenhancementincoreshellmagneticgoldnanoparticleswithtopas
AT wujianan montecarlosimulationofphysicaldoseenhancementincoreshellmagneticgoldnanoparticleswithtopas
AT daizhitao montecarlosimulationofphysicaldoseenhancementincoreshellmagneticgoldnanoparticleswithtopas
AT hurui montecarlosimulationofphysicaldoseenhancementincoreshellmagneticgoldnanoparticleswithtopas
AT xieyaoqin montecarlosimulationofphysicaldoseenhancementincoreshellmagneticgoldnanoparticleswithtopas
AT wangluhua montecarlosimulationofphysicaldoseenhancementincoreshellmagneticgoldnanoparticleswithtopas